Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 11, 2007 CD
Six back issues from 2007 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 11 No. 1 January/February 2007 Pediatric Patients
Vol. 11 No. 2 March/April 2007 Diabetes
Vol. 11 No. 3 May/June 2007 Pain Management
Vol. 11 No. 4 July/August 2007 Hormone Replacement Therapy
Vol. 11 No. 5 September/October 2007 Veterinary Compounding
Vol. 11 No. 6 November/December 2007 High-Technology Compounding

Volume 11, 2007 CD ARTICLES

Volume11, 2007 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: IJPC: The Next 10 Years Vol. 11 No. 1 2
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Vol. 11 No. 1 5
Principles of Pediatric Palliative Care and Pain Control Vol. 11 No. 1 10
Pediatric Oral Formulations: A Continual Challenge Vol. 11 No. 1 17
Sevelamer Suspension in Children with End-Stage Renal Disease Vol. 11 No. 1 20
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Vol. 11 No. 1 26
Case Report: Treatment of Labial Adhesions in a Child Vol. 11 No. 1 27
Compounding In Crisis:The Aftermath of Hurricane Katrina Vol. 11 No. 1 28
Information Resources and Software for the Hospital Compounding Pharmacist Vol. 11 No. 1 36
Psychotropic Medications in the Treatment of Feline Urine Spraying Vol. 11 No. 1 44
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection Vol. 11 No. 1 50
Quality Control Analytical Methods: The Quality of Sterility Testing Vol. 11 No. 1 52
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding Vol. 11 No. 1 56
Pharmacogenomics: The End of Trial-and-Error Medicine? Vol. 11 No. 1 59
Standard Operating Procedure: Refrigerator—Installation,Maintenance, Cleaning, and Power Interruptions Vol. 11 No. 1 66
Calculations Vol. 11 No. 1 68
Caffeine Citrate 10-mg/mL Oral Liquid Vol. 11 No. 1 69
Carbidopa 1.25-mg/mL Oral Liquid Vol. 11 No. 1 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Vol. 11 No. 1 71
Dexamethasone 1-mg/mL Oral Liquid Vol. 11 No. 1 72
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid Vol. 11 No. 1 73
Lansoprazole 3-mg/mL Oral Liquid Vol. 11 No. 1 74
Methyldopa 25-mg/mL Oral Liquid Vol. 11 No. 1 75
Metolazone 1-mg/mL Oral Liquid Vol. 11 No. 1 76
Prednisone 10-mg/mL Oral Liquid Vol. 11 No. 1 77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Vol. 11 No. 1 78
Chemical Stability of Desonide in Ear Drops Vol. 11 No. 1 79
Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Vol. 11 No. 1 82
PostScription: IJPC—More Than a Journal Vol. 11 No. 1 88
PreScription: Putting the Science Back into Pharmacy Vol. 11 No. 2 92
Insulins: Historical and Current Perspectives Vol. 11 No. 2 95
Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh Vol. 11 No. 2 106
Certified Diabetes Educator: A Credential for Compounding Pharmacists Vol. 11 No. 2 112
Challenges of Compounding for Patients on the Ketogenic Diet Vol. 11 No. 2 116
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Vol. 11 No. 2 122
Including Pets in Diabetic Care Vol. 11 No. 2 126
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster Vol. 11 No. 2 131
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh Vol. 11 No. 2 132
Records and Record-Keeping for the Hospital Compounding Pharmacist Vol. 11 No. 2 138
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms Vol. 11 No. 2 145
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations Vol. 11 No. 2 149
Calculations Vol. 11 No. 2 152
Standard Operating Procedure: Discarding of Broken Glass Vol. 11 No. 2 153
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Vol. 11 No. 2 154
Busulfan 2-mg/mL Oral Liquid Vol. 11 No. 2 155
Cefuroxime Axetil 10-mg/mL Oral Liquid Vol. 11 No. 2 156
Metformin Hydrochloride 100-mg/mL Oral Liquid Vol. 11 No. 2 157
Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Vol. 11 No. 2 158
Oral Liquid Vehicle, Anhydrous Vol. 11 No. 2 159
Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Vol. 11 No. 2 160
Ranitidine Hydrochloride 15-mg/mL Oral Liquid Vol. 11 No. 2 161
Tegaserod Meleate 0.1-mg/mL Oral Liquid Vol. 11 No. 2 162
Triprolidine Hydrochloride 0.25-mg/mL Syrup Vol. 11 No. 2 163
Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Vol. 11 No. 2 164
PostScription: Responsibility: A Critical Aspect of Compounding Pharmacy Vol. 11 No. 2 178
PreScription: State or Federal Control of Pharmacy Practice Vol. 11 No. 3 178
Transdermal Gel in the Treatment of Postoperative Pain Vol. 11 No. 3 181
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited Vol. 11 No. 3 187
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids Vol. 11 No. 3 194
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Vol. 11 No. 3 200
Levorphanol for the Treatment of Severe Chronic Pain Vol. 11 No. 3 202
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Vol. 11 No. 3 212
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Vol. 11 No. 3 220
Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations Vol. 11 No. 3 226
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Vol. 11 No. 3 230
Calculations - Compounding for Pain Management Vol. 11 No. 3 238
Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form Vol. 11 No. 3 240
Benazepril 2-mg/mL Oral Liquid Vol. 11 No. 3 242
Cholecalciferol 40,000-IU/mL Oral Liquid Vol. 11 No. 3 243
Folic Acid 1-mg/mL Oral Liquid Vol. 11 No. 3 244
Glycopyrrolate 0.5-mg/mL Oral Liquid Vol. 11 No. 3 245
Isoproterenol Compound Elixir Vol. 11 No. 3 246
Levothyroxine Sodium 40-micro-g/mL Oral Liquid Vol. 11 No. 3 247
Losartan Potassium 2.5-mg/mL Oral Liquid Vol. 11 No. 3 248
Methylphenidate 1-mg/mL Oral Liquid Vol. 11 No. 3 249
Thiamine Hydrochloride 100-mg/mL Oral Liquid Vol. 11 No. 3 250
Trovafloxacin Mesylate 10-mg/mL Oral Liquid Vol. 11 No. 3 251
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations Vol. 11 No. 3 252
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Vol. 11 No. 3 259
PostScription: Lobbying: How It Affects Compounding Vol. 11 No. 3 262
PreScription: Bias, NAMS, and HRT Vol. 11 No. 4 266
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature Vol. 11 No. 4 269
The History of Progesterone Vol. 11 No. 4 274
The Politics of Hormone Replacement Therapy Vol. 11 No. 4 278
Premarin: The Intriguing History of a Controversial Drug Vol. 11 No. 4 282
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement Vol. 11 No. 4 288
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones Vol. 11 No. 4 292
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview Vol. 11 No. 4 297
Book Review: The Rexall Story: A History of Genius and Neglect Vol. 11 No. 4 300
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 11 No. 4 302
Quality-control Analytical Methods: Logbooks and Documentation Forms Vol. 11 No. 4 306
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Vol. 11 No. 4 314
Calculations Vol. 11 No. 4 324
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Vol. 11 No. 4 326
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 328
Ketoconazole 25-mg Liquid Suppository Vol. 11 No. 4 329
Mebeverine Hydrochloride 20% gel Vol. 11 No. 4 330
Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution Vol. 11 No. 4 331
Oseltamivir 12-mg/mL Oral Suspension Vol. 11 No. 4 332
Phenytoin Sodium 20-mg/mL Topical Suspension Vol. 11 No. 4 333
Ribavirin 40-mg/mL Suspension Vol. 11 No. 4 334
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Vol. 11 No. 4 335
Temozolomide 10-mg/mL Oral Liquid Vol. 11 No. 4 336
Vehicle N Formulas Vol. 11 No. 4 337
Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Vol. 11 No. 4 338
Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Vol. 11 No. 4 347
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Vol. 11 No. 4 350
PreScription: Pharmacy Education: Is It Contemporary? Vol. 11 No. 5 354
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine Vol. 11 No. 5 357
Rabbit Medicine Vol. 11 No. 5 364
The Whales: A Pharmacist's Story Vol. 11 No. 5 376
Equine Cushing's Disease: A Clinical Update Vol. 11 No. 5 384
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients Vol. 11 No. 5 390
Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures Vol. 11 No. 5 397
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Vol. 11 No. 5 400
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Vol. 11 No. 5 404
Calculations: Compounding for Veterinary Patients Vol. 11 No. 5 412
Standard Operating Procedure: Complaint and Mishap Rectification Vol. 11 No. 5 414
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs Vol. 11 No. 5 416
Acetylcysteine 200-mg/mL Oral Liquid Vol. 11 No. 5 417
Acetylcysteine 200-mg Packets Vol. 11 No. 5 418
Betamethasone Valerate 0.1% Topical Gel Vol. 11 No. 5 419
Dexpanthenol 5% Gel-Cream Vol. 11 No. 5 420
Diclofenac Sodium 75-mg/mL Injection Vol. 11 No. 5 421
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary Vol. 11 No. 5 422
Hydrocortisone 0.5% Ethanolic Gel Vol. 11 No. 5 423
Neomycin 0.05% Topical Gel Vol. 11 No. 5 424
Nondetergent Neutral Dry Skin Cream Vol. 11 No. 5 425
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Vol. 11 No. 5 426
Isoniazid Release from Suppositories Compounded with Selected Bases Vol. 11 No. 5 433
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Vol. 11 No. 5 438
PreScription: Thoughts on Technology and Pharmacy Vol. 11 No. 6 442
The Internet on Steroids: How Connected is Your Pharmacy? Vol. 11 No. 6 445
Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Vol. 11 No. 6 450
The Internet and Its Websites: Your New Business Partner Vol. 11 No. 6 472
Proteins Used as Sweeteners Vol. 11 No. 6 476
Soda Jerk Vol. 11 No. 6 483
Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds Vol. 11 No. 6 487
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Vol. 11 No. 6 492
Calculations: High-Technology Compounding and Investigational Dispensing Vol. 11 No. 6 500
Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Vol. 11 No. 6 502
Aloe Vera Gel Vol. 11 No. 6 504
Breast Care Cream Vol. 11 No. 6 505
Castor Oil and Trypsin Ointment Vol. 11 No. 6 506
Chlorhexidine 2% Gel Vol. 11 No. 6 507
Coal Tar 2% and Allantoin 2.5% Cream Vol. 11 No. 6 508
Foscarnet 2.5% Topical Cream Vol. 11 No. 6 509
Interferon alfa-2b Ophthalmic Solution Vol. 11 No. 6 510
Lidocaine Hydrochloride 1.82% Buffered Injection Vol. 11 No. 6 511
Miconazole 2% Oral Gel Vol. 11 No. 6 512
Sodium Phenylbutyrate 200-mg/mL Oral Liquid Vol. 11 No. 6 513
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Vol. 11 No. 6 514
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Vol. 11 No. 6 520
PostScription: The History of Pharmacy Vol. 11 No. 6 526